0 Yorumlar
0 hisse senetleri
526 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
- Please log in to like, share and comment!
- Head Lice Infestation Treatment Market to Reach USD 723.7 Million by 2030 | CAGR 4.1%According to a newly published market research report by 24LifeSciences, global head lice infestation treatment market was valued at USD 548.8 million in 2023 and is projected to reach USD 723.7 million by 2030, growing at a compound annual growth rate (CAGR) of 4.1% during the forecast period 2024–2030. Head lice (Pediculus humanus capitis) are parasitic insects that infest human...0 Yorumlar 0 hisse senetleri 406 Views 0 önizleme
- Respiratory Tract Infection Treatment Market to Reach USD 13.5 Billion by 2031 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global respiratory tract infection treatment market was valued at USD 9.8 billion in 2024 and is projected to reach USD 13.5 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 20252031. Respiratory tract infections (RTIs) remain among the most common infectious diseases...0 Yorumlar 0 hisse senetleri 324 Views 0 önizleme
- Systemic Infection Treatment Market to Reach USD 22.1 Billion by 2031 | CAGR 6.4%According to a newly published market research report by 24LifeSciences, global systemic infection treatment market was valued at USD 14.3 billion in 2024 and is projected to reach USD 22.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.4% during the forecast period 2025-2031. Systemic infection treatments combat infections that have spread throughout the bloodstream...0 Yorumlar 0 hisse senetleri 432 Views 0 önizleme
- Uncomplicated Urinary Tract Infection Treatment Market Growth, Comprehensive Analysis Reveals Superb Development Analysis By FMINEWARK, DE – April 7, 2026 — The global uncomplicated urinary tract infection (UTI) treatment market is projected to grow from USD 7.7 billion in 2025 to USD 11.8 billion by 2035, registering a CAGR of 4.4% during the forecast period. The market expansion is primarily driven by rising infection prevalence, increasing awareness, improved diagnostic...0 Yorumlar 0 hisse senetleri 263 Views 0 önizleme